Cumberland Pharmaceuticals, Inc. (CPIX) Reports In-Line Q1 EPS

Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX) reported Q1 EPS of $0.05, in-line with the analyst estimate of $0.05. Revenue for the quarter came in at $10.3 million versus the consensus estimate of $10 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals, Inc. (CPIX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• Wynn Resorts prices $900M senior notes offering at 6.875%
• Copart (CPRT) Misses Q4 EPS by 4c